Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
  1. Home
  2. In The News
  3. Massive Roundup verdict, in wake of EPA ruling, shows how uncertainty and embarrassing emails can trump science

Massive Roundup verdict, in wake of EPA ruling, shows how uncertainty and embarrassing emails can trump science

May 15, 2019 in In The News

Legal Newsline | Daniel Fisher

On April 30, the U.S. Environmental Protection Agency declared glyphosate, the active ingredient in the widely used weedkiller Roundup, to be safe. Less than two weeks later, a California jury ordered Bayer AG to pay $2 billion to a couple who blamed their non-Hodgkin’s lymphoma on Roundup.

How can jurors ignore the nation’s primary regulator, as well as virtually every other national regulatory agency on earth, and decide Roundup caused a relatively common cancer of the bloodstream that even plaintiff medical experts said usually has no identifiable cause? 

The answer is juries do it all the time. Dow Chemical paid billions of dollars to end litigation over silicone breast implants manufactured by its Dow Corning joint venture even though the plaintiffs’ scientific theory that silicone was a slow-acting poison was ultimately shown to be bunk. 

Other examples include the nausea drug Bendectin, falsely accused of causing birth defects, and asbestos lawsuits over automotive brake pads, which large-scale epidemiological studies have shown do not increase the risk of cancer.

The main tools plaintiff lawyers can use to win these large verdicts are scientific uncertainty and incriminating documents, which when combined can convince jurors to switch the burden of proof from the plaintiff to the defendant. 

Click here to read more

January 2, 2020
PilliodScience
SHARE
  • Email
  • Twitter
  • Facebook
  • Google +
  • Pinterest
  • Tumblr
  • Linkedin
  • Vkontakte
  • WhatsApp
Category
  • Filings and Rulings
  • Five-Point Plan
  • In The News
  • Media Statements
  • Resources
    • Documents
    • Infographics
  • Uncategorized
Tags
Ads alesi Benefits carson ferro five-point plan Hardeman Infographics JCCP Johnson MDL Ninth Circuit Pilliod Prop 65 Regulators Roundup Science Settlement Shelton St. Louis City Supreme Court of California

Five-Point Plan to address potential future Roundup™ claims

Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.

Read about the five-point plan here.

Copyright © 2021, All Rights Reserved
Imprint
Privacy Statement

This site was prepared by the Bayer Group for educational purposes only.
For more information on glyphosate herbicides, visit: https://www.bayer.com/en/glyphosate-roundup.aspx.

Copyright © 2019, All Rights Reserved
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
  • Resources
  • Media Center